7 FDA actions
ELIQUIS
BRISTOL MYERS SQUIBB
YERVOY (IPILIMUMAB)
OPDIVO (NIVOLUMAB)
REYATAZ (ATAZANAVIR)
DASATINIB
SUSTIVA